Notch Activation Differentially Regulates Renal Progenitors Proliferation and Differentiation Toward the Podocyte Lineage in Glomerular Disorders by Lasagni, Laura et al.
TISSUE-SPECIFIC STEM CELLS
Notch Activation Differentially Regulates Renal Progenitors
Proliferation and Differentiation Toward the Podocyte Lineage in
Glomerular Disorders
LAURA LASAGNI,
a LARA BALLERINI,
a MARIA LUCIA ANGELOTTI,
a ELIANA PARENTE,
a COSTANZA SAGRINATI,
a
BENEDETTA MAZZINGHI,
a ANNA PEIRED,
a ELISA RONCONI,
a FRANCESCA BECHERUCCI,
a DANIELE BANI,
b
MAURO GACCI,
c MARCO CARINI,
c ELENA LAZZERI,
a PAOLA ROMAGNANI
a,d
aExcellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies
(DENOTHE);
bDepartment of Anatomy, Histology and Forensic Medicine;
cDepartment of Medical and Surgical
Critical Care, University of Florence;
dPediatric Nephrology Unit, Meyer University Hospital, Florence, Italy
Key Words. Renal stem cells • Renal progenitors • Glomerulosclerosis • Kidney • Glomerulonephritis
ABSTRACT
Glomerular diseases account for 90% of end-stage kidney
disease. Podocyte loss is a common determining factor for
the progression toward glomerulosclerosis. Mature podo-
cytes cannot proliferate, but recent evidence suggests that
they can be replaced by renal progenitors localized within
the Bowman’s capsule. Here, we demonstrate that Notch
activation in human renal progenitors stimulates entry into
the S-phase of the cell cycle and cell division, whereas its
downregulation is required for differentiation toward the
podocyte lineage. Indeed, a persistent activation of the
Notch pathway induced podocytes to cross the G2/M check-
point, resulting in cytoskeleton disruption and death by mi-
totic catastrophe. Notch expression was virtually absent in
the glomeruli of healthy adult kidneys, while a strong up-
regulation was observed in renal progenitors and podocytes
in patients affected by glomerular disorders. Accordingly,
inhibition of the Notch pathway in mouse models of focal
segmental glomerulosclerosis ameliorated proteinuria and
reduced podocyte loss during the initial phases of glomeru-
lar injury, while inducing reduction of progenitor prolifera-
tion during the regenerative phases of glomerular injury
with worsening of proteinuria and glomerulosclerosis.
Taken altogether, these results suggest that the severity of
glomerular disorders depends on the Notch-regulated bal-
ance between podocyte death and regeneration provided by
renal progenitors. STEM CELLS 2010;28:1673–1685
Disclosure of potential conﬂicts of interest is found at the end of this article.
INTRODUCTION
Glomerular diseases account for 90% of end-stage kidney disease
[1]. Depletion of podocytes, which are highly specialized cells
that are critical constituents of the glomerular ﬁltration barrier, is
key for progression of glomerular disorders toward glomeruloscle-
rosis [2–5]. However, converging evidence demonstrated that in
adult kidneys podocytes can get replaced from a resident popula-
tion of progenitors localized along the inner surface of the Bow-
man’s capsule [6–11]. These renal progenitors can generate podo-
cytes via their division and migration along the Bowman’s
capsule toward the glomerular tuft, where complete differentiation
into podocytes occurs [9–12]. In humans, renal progenitors are
characterized by the presence of surface markers, CD133 and
CD24 [6–10, 12]. Understanding of how self-renewal and fate de-
cision of renal progenitors may be perturbed in pathological con-
ditions is of crucial importance. Indeed, recent results demon-
strated that abnormal proliferation of renal progenitors can
generate glomerular lesions in focal segmental glomerulo-
sclerosis (FSGS) and crescentic glomerulonephritis [13, 14],
suggesting that the response of renal progenitors to podocyte
injury is critical to achieve remission or progression of glo-
merular disorders [15, 16]. However, the mechanisms that
regulate the growth and differentiation of renal progenitors
are still unknown.
The pathways involved in stem/progenitor cell function are
mostly conserved in adult organs [17]. In particular, the Notch
pathway affects cell fate choices of stem/progenitor cells,
including the decisions to self-renew or differentiate [17–21].
In mammals, there are four single-pass transmembrane Notch
receptors (Notch1/2/3/4) and ﬁve transmembrane ligands,
Delta-like (Dll)-1/3/4, Jagged (Jag)-1/2. On activation, the
Notch intracellular domain (NICD) is cleaved by c-secretases
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tional regulator recombination signal-binding protein-J (RBP-J)
[17–21], then activates the downstream transcriptional targets
such as the Hairy enhancer of split (Hes) factors and Hes-
related repressor proteins (Hey) [17–22].
In this study, the role of Notch signaling in the growth/
differentiation of renal progenitors toward the podocyte line-
age was investigated. We found that activation of the Notch
pathway in human renal progenitors stimulated their entry
into the S-phase of the cell cycle and cell division, while a
downregulation of the Notch pathway was required for their
differentiation toward the podocyte lineage. Indeed, persistent
activation of the Notch pathway induced podocytes to cross
the cell cycle G2/M checkpoint, resulting in cytoskeleton dis-
ruption and death by mitotic catastrophe. Notch activation
was virtually undetectable in glomeruli of healthy adult kid-
neys, but it was observed in renal progenitors and podocytes
of patients affected by glomerular disorders. Accordingly, in-
hibition of the Notch pathway in mice models of FSGS ame-
liorated proteinuria and reduced podocyte death during the ini-
tial phases of glomerular injury, whereas it induced worsening
of proteinuria and reduction of renal progenitor proliferation
during the regenerative phases of chronic glomerular injury.
Taken altogether, these results suggest that a regulated activa-
tion of the Notch pathway in renal progenitors during their
phases of differentiation toward the podocyte lineage is criti-
cal to balance injury and regeneration in glomerular disorders.
MATERIALS AND METHODS
Patients
We studied kidney biopsy specimens of patients with systemic
lupus erythematosus (LES) nephritis (n ¼ 15) and FSGS (n ¼
10). Normal renal tissues were obtained from patients (n ¼ 8)
nephrectomized because of renal cell carcinoma, in agreement
with the Ethical Committee on human experimentation of the
Azienda Ospedaliero-Universitaria Careggi, Florence.
Human Renal Progenitor Cultures and In Vitro
Differentiation
Human renal progenitors were obtained and cultured as previ-
ously described [6–10]. For podocyte differentiation, cells were
treated for 2 days with vitamin D3, retinoic acid and dexametha-
sone-supplemented DMEM/F12 (VRADD) medium composed of
Dulbecco(s modiﬁed Eagle medium (DMEM)-F12 (Sigma, ST.
Louis, MO, USA, www.sigmaaldrich.com) supplemented with
10% fetal bovine serum (FBS) (Hyclone, from Euroclone, Milan,
Italy; www.euroclonegroup.it), 100 nM vitamin D3, 100 lM all-
trans retinoic acid and 0.1 lM Dexamethasone (all from Sigma).
Cell Proliferation Assay
3[H]-thymidine incorporation was assessed as described [23]. The
c-secretase inhibitor IX DAPT (N-[N-(3,5-Diﬂuorophenacetyl)-L-
alanyl]-S-phenylglycine t-butyl ester) was obtained from Merck,
KGaA, Darmstadt, Germany (www.merck.com).
Human Renal Progenitor Infection
N1ICD (5275–7332 bp), N2ICD (5094–7413 bp), or N3ICD
(4954–6996 bp) were polymerase chain reaction (PCR)-ampliﬁed
from renal progenitor cells cDNA and cloned into the bicistronic
pLVX-IRES-sGreen1 lentiviral vector (Clontech, Mountain View,
CA, USA, www.clontech.com) leading to the gene-of-interest and
the ZsGreen1 ﬂuorescent protein to be simultaneously coexpressed
from a single mRNA transcript. Lentiviral particles were produced
by cotransfection of the lentiviral and the three third-generation
packaging vectors into Lenti-X 293T cells (Clontech). Titers were
determined by infection of 293T cells and ranged from 0.2   10
6
to 2   10
6 infectious particles per milliliter.
Human renal progenitors were infected with virus-containing su-
pernatant with a multiplicity of infection (MOI) of 10 as well as fresh
endothelial cell growth medium-microvascular (EGM-MV) media, in
t h ep r e s e n c eo f8lg/ml of polybrene (Sigma). Level of infection was
assessed by measuring percentages of ZsGreen1þ cells by ﬂow
cytometry. Percentages of infected cells ranged from 40% to 90%.
RBP-J Reporter System
pGreenFire1 (pGF1)-Notch reporter plasmid, which expresses
ﬁreﬂy luciferase reporters under the control of RBP-J and the
control empty vector, were obtained from System Biosciences
(SBI, Mountain View, CA, USA, www.systembio.com). Lentivi-
ral particles were produced as described earlier and human renal
progenitors were infected with a MOI of 30.
Cell Cycle Analysis and Propidium Iodide/Annexin V
Staining
Cell cycle analysis was performed as previously described and an-
alyzed with the Modﬁt LT 3.0 software (Verity Software House
Inc., Topsham, ME, USA, www.vsh.com) [23]. Apoptosis and/or
necrosis were evaluated using propidium iodide (PI) and the
Annexin V kit (BD Biosciences, San Diego, CA, USA, www.bdbio
sciences.com) and the FACSDiva software.
Immunoﬂuorescence and Confocal Microscopy
Confocal microscopy was performed on 5 lm sections of renal
frozen tissues or on cells by using a LSM510 META laser confo-
cal microscope (Carl Zeiss, Jena, Germany, www.zeiss.com) as
described previously [6–8]. The following antibodies were used:
anti-Notch1 pAb Val1744 (recognizing NICD), anti-Notch3 pAb
(recognizing NICD), anti-Dll4 pAb (all from Abcam, Cambridge,
U.K., www.abcam.com); Notch2 pAb (recognizing NICD, Rock-
land, Gilbertsville, PA, USA, www.rockland-inc.com); anti-Notch1
pAb C-20 (recognizing NICD), anti-Jag1 pAb, anti-Jag2 pAb,
anti-nephrin pAb, anti-CD24 mAb (clone SN3), anti-WT1 mAb
(clone F-6; all from Santa Cruz Biotechnologies, Santa Cruz, CA,
USA, www.scbt.com); anti-Hes1 pAb (Chemicon, Temecula, CA,
USA, www.chemicon.com); anti-Dll1 mAb (clone 251123, R&D
Systems, Minneapolis, MN, USA, www.rndsystems.com), anti-
H3-Ser10 mAb (anti-phospho histone H3, Abcam); anti-Claudin-1
mAb (clone 2H10D10, Invitrogen, Carlsbad, CA, USA, www.invi-
trogen.com); anti-H3-Ser10 pAb (Cell Signaling, Danvers, MA,
USA, www.cellsignal.com), anti-a-tubulin mAb (clone B512,
Sigma); anti-podocalyxin (PDX) mAb (clone 222328, R&D Sys-
tems); anti-cytokeratin mAb (CK, clone C-2562, Sigma). Stain-
ing with Alexa Fluor546 phalloidin (Molecular Probes, Invitro-
gen) was performed following manufacturer’s instructions.
Double immunolabeling was performed as described and Alexa-
Fluor secondary antibodies were obtained from Molecular
Probes.
Analysis of Renal Morphology and Quantiﬁcation of
Nephrin Positive Cells and Mitotic Cells
Five micrometer-thick kidney sections of mice treated with vehi-
cle and DAPT, killed at days 7 and 21, were analyzed. For quan-
titation of podocytes or mitotic podocytes, the number of nephrin
positive cells or of H3-Ser10/Nephrin double positive cells was
evaluated in 15 glomeruli of at least four sections for each mouse
by two independent observers. For quantitation of mitotic renal
progenitors, the number of H3-Ser10/Claudin-1 double positive
cells was evaluated by two independent observers in at least six
sections for each mouse.
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Kidney tissue samples of about 2 mm
3 obtained from four DAPT-
treated mice and four oil-treated mice were ﬁxed in glutaralde-
hyde-osmium tetroxide, embedded in epoxy resin and routinely
processed for transmission electron microscopical observation.
Ultrathin sections were cut using a LKB-Nova ultramicrotome
(LKB, Bromma, Sweden, www.lkb.com), counterstained with ura-
nyl acetate and alkaline bismuth subnitrate, and examined under a
JEM 1010 transmission electron microscope (Jeol, Tokyo, Japan,
www.jeol.com) at 80 kV.
Real-Time Quantitative Reverse Transcription PCR
Taq-Man reverse transcription (RT)-PCR was performed as previ-
ously described [24]. Notch1, Notch2, Notch3, Notch4, Dll1,
Dll3, Dll4, Jag1, Jag2, Hes1, Hes2, Hes3, Hes4, Hes5, Hes6,
Hes7, Hey1, Hey2, HeyL, nephrin, p21, p27, and Aurora kinase
B quantiﬁcation was performed using Assay on Demand kits
(Applied Biosystems, Warrington, U.K., www.appliedbiosystems.
com).
Severe Combined Immunodeﬁcient (SCID) Mouse
Model of Adriamycin Nephropathy
Animal experiments were performed in accordance with institu-
tional, regional, and state guidelines and in adherence to the
National Institutes of Health Guide for the Care and Use of Labo-
ratory Animals. Adriamycin nephropathy was induced in female
SCID mice (Harlan, Udine, Italy, www.harlan.com) at the age of
6 weeks by a single i.v. injection of adriamycin (6 mg/kg in
phosphate buffered saline (PBS), Sigma) on day 0 in the tail vein
(n ¼ 12) in a total of three independent experiments. As controls,
another group of mice (n ¼ 12) received PBS. Proteinuria was
evaluated on day 0 and again on days 7, 14, 21, 28, 35, and 42
in adriamycin or PBS-treated SCID mice. In each of the same
experiments, 28 additional mice treated as described earlier were
killed at day 0 (n ¼ 4), 7 (n ¼ 4), 14 (n ¼ 4), 21 (n ¼ 4), 28 (n
¼ 4), 35 (n ¼ 4), and 42 (n ¼ 4) for analysis of renal morphol-
ogy and Notch immunoﬂuorescence.
Additional groups of mice received oral gavage of DAPT (5
mg/kg in corn oil, Calbiochem, Merck) or of vehicle (corn oil)
once a day from 2 days before the day of adriamycin injection to
the end of the experiment, as follows: group 1, vehicle (n ¼ 15);
group 2, DAPT (n ¼ 15) in a total of three independent experi-
ments. In each of the same experiments, 20 additional mice were
killed at day 7 (n ¼ 5), 14 (n ¼ 5), 21 (n ¼ 5), and 28 (n ¼ 5)
after adriamycin injection for analysis of renal morphology. Uri-
nary albumin and creatinine in 24 hours urine were determined
with Albuwell M kit (Exocell, Philadelphia, PA, USA, www.exo-
cell.com) and Creatinine Assay kit (Cayman Chemical, Ann
Arbor, MI, USA, www.caymanchem.com).
Statistical Analysis
The results were expressed as mean 6 SEM. Comparison
between groups was performed by the Mann-Whitney test, the
Wilcoxon test, or through the analysis of variance for multiple
comparisons (ANOVA; ANOVA for repeated measures). p < .05
was considered to be statistically signiﬁcant.
RESULTS
Notch Activation Induces Proliferation of Renal
Progenitors
First of all, we examined the mRNA and protein expression
proﬁles of Notch ligands and receptors in cultured human re-
nal progenitor cells. Renal progenitors expressed Notch1,
Notch2, and Notch3, whereas expression of Notch4 was irrel-
evant (Fig. 1A, 1B). Notch2 mRNA levels were signiﬁcantly
higher than those of Notch1 and Notch3 (p < .05). Among
Notch ligands, Dll1, Dll4, Jag1 and Jag2 were all present in
human renal progenitors. Jag1 exhibited the highest expres-
sion level (p < .05), and Jag2 was signiﬁcantly more
expressed than Dll1 and Dll4 (p < .05; Fig. 1C, 1D), whereas
Dll3 was not detectable (Fig. 1C). Detection of Notch1,
Notch2, and Notch3 proteins within nuclei using antibodies
against the NICDs suggested that the Notch signaling pathway
was active in most renal progenitors. Accordingly, infection
with a RBP-J-responsive luciferase vector induced activation
of the RBP-J-dependent promoter reporter, further conﬁrming
that the Notch pathway was chronically active in human renal
progenitors culture (Fig. 1E).
To investigate the role of Notch signaling on renal pro-
genitor proliferation, cells were exposed to different concen-
trations of the c-secretase inhibitor DAPT, which inhibits
the signaling pathway of all Notch receptor types. Assess-
ment of
3H-thymidine incorporation demonstrated that
DAPT-treatment induced a dose-dependent growth inhibition
(Fig. 1F), which resulted in a reduction of renal progenitor
numbers (Fig. 1G). Viability of 10 lM DAPT-treated and
DAPT-untreated cells was comparable (94.6% 6 0.7% vs.
93.6% 6 0.9%; NS), as evaluated by using a combined ﬂu-
orescence activated cell sorting (FACS) analysis for PI and
annexin V staining (Fig. 1H), thus demonstrating that inhi-
bition of the Notch pathway was not associated with a
reduction in renal progenitor viability.
Notch Downregulation Is Necessary to Achieve
Differentiation of Human Renal Progenitors into
the Podocyte Lineage
In agreement with previous studies [10], culturing of human
renal progenitors in the VRADD medium resulted in their
differentiation into podocytes, as demonstrated by novel
expression of nephrin, which is the most speciﬁc marker of
podocytes (Fig. 2A). Interestingly, differentiation of human
renal progenitors into podocytes was associated with a
reduction of Notch1-3 protein expression (Fig. 2B) and with
a downregulation of the Notch-target genes Hes1 and Hes5
(Fig. 2C), and of the RBP-J-dependent promoter reporter
activation (Fig. 2D). The fact that only Hes1 and Hes5 and
not other target genes were downregulated is in agreement
with observations in other stem/progenitor cell types, which
also reported that Notch-related effects on proliferation and/
or differentiation can be speciﬁcally mediated by Hes1 and/
or Hes5 [25–27]. To evaluate the possible role of Notch sig-
naling shutdown in the differentiation of human renal pro-
genitors, cells were exposed to DAPT for 48 hours and
expression of podocyte markers was assessed. DAPT treat-
ment induced Notch signaling inhibition, as demonstrated by
the decrease in Hes1 mRNA levels (data not shown), but
the expression of the podocyte marker nephrin was unaf-
fected (Fig. 2E), thus demonstrating that downregulation of
the Notch pathway was not sufﬁcient to induce the differen-
tiation of renal progenitors.
To investigate whether the downregulation of Notch sig-
naling was however necessary for the differentiation into the
podocyte lineage, we induced a sustained Notch signaling via
the infection of renal progenitors with a recombinant lentivi-
rus, which encoded the intracellular domain of the three
Notch receptors: N1ICD, N2ICD, or N3ICD (Fig. 3A). Infec-
tion of NICDs resulted in an upregulation of RBP-J
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infected renal progenitors were then induced to differentiate
into podocytes (Fig. 3B). Treatment with VRADD turned off
almost completely the Notch pathway in mock-infected pro-
genitors, while it exerted only a minor effect on NICD-
infected renal progenitors (Fig. 3B). The differentiation pro-
cess occurred normally in mock-infected renal progenitors,
but it was perturbed in NICD-infected cells (Fig. 3C, 3D).
Indeed, most of the NICD-infected renal progenitors detached
from the plate and died following differentiation toward the
podocyte lineage (Fig. 3D). However, the few surviving cells
expressed levels of nephrin as high as those expressed by
mock-infected renal progenitors after their differentiation
(Fig. 3C). Similar effects were observed independently of the
type of NICD infected (Fig. 3C, 3D) and of the level of
NICD expression of RBP-J transactivation achieved.
Figure 1. Expression and functional properties of Notch receptors and ligands on human renal progenitors. (A): mRNA levels for Notch recep-
tors as assessed by real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) in cultures of renal progenitor cells. Results
are expressed as mean 6 SEM of triplicate assessments in primary cultures from ﬁve different donors. b versus a, c and a versus c: p < .05.
(B): Double label immunoﬂuorescence for Notch1, Notch2, or Notch3 (green) and CD24 (red) in renal progenitors, as assessed by confocal mi-
croscopy. Topro-3 (blue) counterstains nuclei. One representative of seven independent experiments is shown. Scale bar ¼ 50 lm. (C): mRNA
levels for Notch ligands as assessed by real-time quantitative RT-PCR in cultures of renal progenitors. Results are expressed as mean 6 SEM of
triplicate assessments in primary cultures from ﬁve different donors. c versus a, b, d and d versus a, b: p < .05. (D): Double label immunoﬂuo-
rescence for Dll1, Dll4, Jag1, or Jag2 (green) and CD24 (red) in renal progenitors, as assessed by confocal microscopy. Topro-3 (blue) counter-
stains nuclei. One representative of seven independent experiments is shown. Scale bar ¼ 50 lm. (E): Activation of the Notch pathway in renal
progenitors as assessed by infection with a RBP-J-responsive luciferase vector. Results are expressed as mean 6 SEM of relative luciferase units
in comparison with human renal progenitors infected with the empty vector as obtained in nine independent experiments. (*, p < .05). (F): Effect
of DAPT (0–50 lM) treatment on the proliferative capacity of renal progenitors, as assessed by
3[H]-thymidine incorporation. Results represent
mean values 6 SEM obtained in four separate experiments from ﬁve different donors (*, p < .05). (G): Growth curves showing the effect of
DAPT treatment on renal progenitor numbers. Results are expressed as mean 6 SEM of cell numbers obtained in four separate experiments from
ﬁve different donors (*, p < .05). (H): FACS analysis of renal progenitor cell viability following their treatment with DAPT, as assessed by
annexin-V, and propidium iodide staining. One representative of four experiments is shown. Abbreviations: DAPT, N-[N-(3,5-Diﬂuorophenace-
tyl)-L-alanyl]-S-phenylglycine t-butyl ester; RBP-J, recombination signal-binding protein-J; FACS, ﬂuorescence activated cell sorting, RLU, rela-
tive luminescence unit.
1676 Notch Activation in Renal ProgenitorsInterestingly, an almost complete exhaustion of the Notch ac-
tivity was required to avoid death of renal progenitors during
their differentiation toward the podocyte lineage. Indeed, sim-
ilar levels of Notch activity had no effect on survival and pro-
moted growth of undifferentiated renal progenitors, but they
were incompatible with differentiation. These results suggest
that the death-promoting effect of Notch activation in podo-
cytes was cell type-speciﬁc and was not related to Notch
overexpression.
Notch Activation Differentially Regulates Cell Cycle
Progression and Checkpoint Arrest in Renal
Progenitors and Podocytes
We then evaluated the cell cycle distribution of mock- and
NICD-infected human renal progenitors maintained in undif-
ferentiated conditions or induced to differentiate toward the
podocyte lineage. Cells were synchronized by detachment and
plating, and immediately after adhesion, medium was changed
and renal progenitors were either maintained in basal medium
or treated with podocyte differentiating medium. Analysis of
the cell cycle distribution after 48 hours demonstrated that in
NICD-infected undifferentiated renal progenitors the percent-
age of cells in the S-phase was signiﬁcantly increased in com-
parison with mock-infected cells (36.5 6 2.7 vs. 19.8 6 2.5,
p < .05; Fig. 4A vs. 4B). When mock-infected renal progeni-
tors were induced to differentiate toward the podocyte line-
age, they synchronized into the G2/M phase of the cell cycle
(30.8 6 6.5 vs. 8.7 6 2.6, p < .05; Fig. 4C vs. 4A), in agree-
ment with previous observations [28]. However, if NICD-
infected renal progenitors were induced to differentiate toward
the podocyte lineage, there was a substantial reduction of the
number of cells in the G2/M phase (11.7 6 1.9 vs. 30.8 6
6.5, p < .05; Fig. 4C vs. Fig. 4D) and a concurrent impres-
sive podocyte detachment. Similar effects were observed inde-
pendently of the type of NICD infected. These results suggest
that sustained Notch activation during differentiation toward
Figure 2. Notch pathway downregulation during human renal progenitors differentiation toward the podocyte lineage. (A): Left: Nephrin
mRNA levels in renal progenitors before and after culture in VRADD medium, as assessed by real time quantitative reverse transcription poly-
merase chain reaction (RT-PCR). Results are expressed as mean 6 SEM of fold level increase for nephrin mRNA before (control) and after 48
hours of culture in VRADD medium obtained in four separate experiments. Right: Nephrin protein expression (green) in renal progenitors as
assessed by confocal microscopy before (top) and after (bottom) 48 hours of culture in VRADD medium. Topro-3 (blue) counterstains nuclei.
One representative of four independent experiments is shown. Scale bar ¼ 50 lm. (B): Notch1, Notch2, and Notch3 protein expression (green)
as assessed by confocal microscopy in control cells (top) and after 48 hours of culture in VRADD medium (bottom). Topro-3 (blue) counterstains
nuclei. One representative of eight independent experiments is shown. Scale bar ¼ 50 lm. (C): Notch-target genes mRNA levels in renal progen-
itors before (control) and after 48 hours of culture in VRADD medium, as assessed by real time quantitative RT-PCR. Results are expressed as
mean 6 SEM obtained in six separate experiments. (*, p < .05). (D): Downregulation of the Notch pathway activity in renal progenitors follow-
ing differentiation toward the podocyte lineage, as assessed by infection with a reporter vector for the RBP-J transcriptional response element.
Results are expressed as mean 6 SEM fold increase of luciferase activity in comparison with renal progenitors infected with the empty expres-
sion vector as obtained in eight independent experiments. (*, p < .05). (E): Effect of DAPT treatment on the increase of mRNA level for nephrin
in renal progenitors before (control) and after 48 hours of culture in VRADD medium. Results are expressed as mean 6 SEM of fold level
increase obtained in four separate experiments. Abbreviations: DAPT, N-[N-(3,5-Diﬂuorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester; fgs,
femtograms; RBP-J, Recombination signal-binding protein-J; RLU, relative luminescence unit; VRADD, vitamin D3, retinoic acid and dexameth-
asone-supplemented DMEM/F12.
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point and promotes cell death. To support this possibility, the
percentage of apoptotic and/or necrotic progenitors and podo-
cytes in mock- or NICD-infected cells was evaluated by using
a combined FACS analysis for PI and annexin V (Fig. 4E–
4H). The percentage of dead cells was analyzed including ad-
herent and detached cells ﬂoating in the supernatant. Renal
progenitors showed a negligible percentage of dead cells, in-
dependently of the level of Notch expression (Fig. 4E, 4F).
By contrast, following their differentiation toward the podo-
cyte lineage, NICD expression increased the percentage of
dead cells among NICD-infected progenitors in comparison
with mock-infected progenitors (5.1 6 0.9 vs. 21.1 6 2.1,
p < .05; Fig. 4G vs. 4H). Taken together, these results sug-
gest that Notch activation impairs the progression of podo-
cytes through mitosis. We thus evaluated the appearance of
mitotic divisions in renal progenitors before and after their
differentiation toward podocytes using double immunoﬂuores-
cence analysis for the phosphorylated Histone H3-serine 10
(H3-Ser10), a mitosis marker, and the mitotic spindle compo-
nent tubulin. Normal mitoses were observed in undifferenti-
ated mock-infected renal progenitors, which displayed a con-
served cytoskeleton structure and normal nuclear ploidy (Fig.
4I), that were not inﬂuenced by infection with NICDs (Fig.
4J). By contrast, following their differentiation toward podo-
cytes, NICD-infected progenitors revealed the presence of
aberrant mitoses, binucleated or micronucleated cells and a
disrupted cytoskeleton (Fig. 4L) in comparison with their re-
spective mock-infected cells (Fig. 4K), thus suggesting death
by mitotic catastrophe.
To establish the reason for the different effect of Notch
activation on mitotic division in undifferentiated versus differ-
entiated renal progenitors, we evaluated the mRNA levels of
the cell cycle regulators, p21
Cip1/WAF-1, p27
Kip1. Aurora kinase
B, which plays a critical role in mitotic entry and chromo-
some segregation, was also evaluated. Infection of renal pro-
genitors with NICDs consistently resulted in the upregulation
of transcription of Aurora kinase B (p < .05 vs. mock; Fig.
4M), as well as in a downregulation of p27
Kip1 (p < .05 vs.
mock; Fig. 4N). By contrast, differentiation of renal progeni-
tors toward the podocyte lineage resulted in a strong down-
regulation of Aurora kinase B transcription (p < .05 Fig. 4O
vs. mock in Fig. 4M) and upregulation of p21
Cip1/WAF-1 and
p27
Kip1 (p < .05 Fig. 4P vs. mock in Fig. 4N), which is
Figure 3. Notch downregulation is necessary to achieve differentiation of human renal progenitors into the podocyte lineage. (A): Sustained
Notch protein expression in renal progenitors as obtained following infection with a vector leading to the N1ICD, N2ICD, or N3ICD and the
GFP to be simultaneously coexpressed. Cells infected with the empty vector (mock) express GFP but do not express the NICDs. Uninfected cells
are shown for comparison. One representative of 10 independent experiments is shown. (B): Downregulation of the Notch pathway activity fol-
lowing differentiation of renal progenitors toward the podocyte lineage is rescued by infection with vectors expressing N1ICD, N2ICD, or
N3ICD as demonstrated by coinfection with a reporter vector for the RBP-J transcriptional response element. Results are expressed as mean 6
SEM fold increase of luciferase activity in renal progenitors coinfected with a reporter vector for the RBP-J and the vectors expressing N1ICD,
N2ICD, or N3ICD in comparison with the empty vector before (control) or after their differentiation toward the podocyte lineage (VRADD) as
obtained in at least four independent experiments. b versus a, c, d, e, f, g, h: p < .05; a versus c, e, g: p < .05; a versus d, e versus f, and g ver-
sus h: NS.( C): Analysis of nephrin mRNA fold increase after VRADD culture in renal progenitors infected with an empty vector (mock) and
with vectors expressing N1ICD, N2ICD, or N3ICD. Results are expressed as mean 6 SEM obtained in four separate experiments. (D): Effect of
infection with mock vector and vector expressing N1ICD, N2ICD, or N3ICD on cell number after 48 hours of culture in VRADD medium.
Results are expressed as mean 6 SEM of triplicate assessment as obtained in four separate experiments (*, p < .05). Abbreviations: GFP, green
ﬂuorescent protein; RBP-J, recombination signal-binding protein-J; RLU, relative luminescence unit; NICD, Notch intracellular domain; NS, not
signiﬁcant; VRADD, vitamin D3, retinoic acid and dexamethasone-supplemented DMEM/F12.
1678 Notch Activation in Renal ProgenitorsFigure 4. Regulation of cell cycle progression, mitosis, cell death, and cytoskeleton organization in N3ICD-infected human renal progenitors
before and after differentiation toward the podocyte lineage. (A, B): Cell cycle analysis performed on (A) mock- and (B) N3ICD-infected renal
progenitors. One representative of four independent experiments is shown. (C, D): Cell cycle analysis performed on (C) mock- and (D) N3ICD-
infected renal progenitors after their differentiation toward the podocyte lineage. One representative of four independent experiments is shown.
(E, F): FACS analysis of apoptosis/necrosis in mock- and N3ICD-infected renal progenitors as assessed by annexin-V and propidium iodide (PI)
staining. One representative of four independent experiments is shown. (G, H): FACS analysis of apoptosis/necrosis in mock- and N3ICD-
infected renal progenitors after their differentiation toward the podocyte lineage as assessed by annexin-V and PI staining reveals an increase in
the percentage of PI/annexin V positive cells in N3ICD-infected cells. One representative of four independent experiments is shown. (I, J):
Above: H3-Ser10 (red) and tubulin (blue) staining of mock- and N3ICD-infected undifferentiated renal progenitors reveals normal mitoses. For
mock-infected cells, a representative metaphase is shown, while for N3ICD-infected cells, a representative anaphase is shown. One representative
of six independent experiments is shown. Scale bar ¼ 10 lm. Below: Phalloidin staining (red) of mock- and N3ICD-infected undifferentiated re-
nal progenitors. Topro-3 (blue) counterstains nuclei. One representative of six independent experiments is shown. Scale bar ¼ 50 lm. (K, L):
Above: H3-Ser10 (red) and tubulin (blue) staining of renal progenitors infected with vector expressing N3ICD (L) after their differentiation to-
ward the podocyte lineage reveals aberrant mitoses characterized by micro/multinucleation (red) and abnormal spindle distribution (blue) in com-
parison with those infected with an empty vector (mock, [K]). One representative of six independent experiments is shown. Scale bar ¼ 10 lm.
Below: Phalloidin staining (red) of mock- (K) and N3ICD-infected (L) renal progenitors after their differentiation toward the podocyte lineage
reveals F-actin ﬁlaments distributed as stress-like bundles along the axis of the cells in mock-infected podocytes and redistribution of F-actin
ﬁbers to the periphery of the cells in podocytes infected with N3ICD. Topro-3 (blue) counterstains nuclei. One representative of six independent
experiments is shown. Scale bar ¼ 50 lm. (M, N): Assessment by real-time quantitative reverse transcription polymerase chain reaction (RT-
PCR) of Aurora kinase B (M), p21
Cip1/WAF-1 and p27
Kip1 (N) mRNA expression in mock- and N3ICD-infected undifferentiated renal progenitors.
Results are expressed as mean 6 SEM of triplicate assessments in seven separate experiments. (O, P): Assessment by real-time quantitative RT-
PCR of Aurora kinase B (O) and p27
Kip1, p21
Cip1/WAF-1 (P) mRNA expression in mock- and N3ICD-infected renal progenitors after their differ-
entiation toward the podocyte lineage. Results are expressed as mean 6 SEM of triplicate assessments in seven separate experiments. Abbrevia-
tion: FACS, ﬂuorescence activated cell sorting.
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ever, in NICD-infected podocytes, a downregulation in the
transcription of p21
Cip1/WAF-1 and p27
Kip1 in comparison with
mock podocytes (p < .05 vs. mock; Fig. 4P) was observed,
suggesting that progression through the cell cycle could not
be arrested. Furthermore, in presence of low levels of Aurora
kinase B (p < .05 vs. mock; Fig. 4O), cells could not assem-
ble a functional mitotic spindle, suggesting that they overrode
the G2/M checkpoint and progressed through an aberrant mi-
tosis. Similar effects were observed independently of the type
of NICD infected (Supporting Information Fig. 1 and 2) and
of the level of Notch activation achieved. Taken together,
these results demonstrate that Notch activation upregulates
Aurora Kinase B and induces progression through the cell
cycle and cell division in undifferentiated human renal pro-
genitors. By contrast, Notch activation in podocytes, which
express irrelevant levels of Aurora kinase B, induces cell
cycle progression in cells that cannot assemble a functional
mitotic spindle thus causing death by mitotic catastrophe.
Activation of the Notch Pathway in Renal
Progenitors and Podocytes in Patients Affected by
Glomerular Disorders Related to Podocyte Injury
To assess the expression of components of the Notch signal-
ing pathway in healthy and pathologic kidneys, we performed
immunoﬂuorescence for Notch1, Notch2, and Notch3 in nor-
mal human kidneys or in kidney biopsies from patients
affected by different types of glomerular disorders character-
ized by severe podocyte injury, such as LES nephritis and
FSGS (Fig. 5). To evaluate the expression of Notch1, Notch2,
and Notch3 in podocytes or renal progenitors, we utilized
antibodies that selectively recognized the intracellular domain,
thus allowing identiﬁcation of the cells in which activation of
the Notch pathway had occurred. The expression of Notch1
and Notch3 was virtually undetectable in normal kidneys
(Fig. 5A, 5B), but clearly evident in nuclei of podocytes
within the glomeruli of patients with LES nephritis or FSGS,
as demonstrated by double immunolabeling with the podocyte
marker PDX (Fig. 5D, 5F). Similar results were observed also
for Notch2, although this receptor was expressed at lower
level (data not shown). In addition, Notch3 expression was
observed in nuclei of renal progenitors, as demonstrated by
their costaining with the renal progenitor marker CD24 (Fig.
5G–5H), whereas Notch1 expression was more rarely detected
(Fig. 5E). Likewise, the expression of Hes1 was scarce and
limited to a few cells within the glomeruli in healthy kidneys
(Fig. 5C), but it was strongly expressed in podocytes as well
as in renal progenitors of patients with LES nephritis or
FSGS (Fig. 5I, 5J).
Notch Inhibition Differentially Regulates Podocyte
Injury and Regeneration in Mice with FSGS
To evaluate the role of the Notch pathway in the regenerative
properties of renal progenitors following podocyte injury in
vivo, we used adriamycin-induced nephropathy, which is an
experimental analogue of human FSGS [29]. Lymphocytes
contribute to renal injury in adriamycin nephropathy [29, 30],
and the Notch pathway also plays a crucial role in regulating
the function of T lymphocytes. Thus, to evaluate the role of
the Notch pathway in renal injury and regeneration irrespec-
tively of the interference of T lymphocytes, we established
models of adriamycin-induced nephropathy in SCID mice.
SCID mice treated with adriamycin developed functional and
histological changes similar to those of immunocompetent
mice, displaying a signiﬁcant proteinuria after 7 days, that
Figure 5. Upregulation of the Notch signaling components in
glomeruli of patients affected by LES nephritis or focal segmental
glomerulosclerosis (FSGS). (A): Double label immunoﬂuorescence
for Notch1 (green) and CD24 (red) in healthy adult human kidneys.
Scale bar ¼ 50 lm. (B): Double label immunoﬂuorescence for
Notch3 (green) and PDX (red) in healthy adult human kidneys.
Scale bar ¼ 50 lm. (C): Double label immunoﬂuorescence for Hes1
(green) and PDX (red) in healthy adult human kidneys. Scale bar ¼
50 lm. (D): Double label immunoﬂuorescence for Notch1 (green)
and PDX (red) in a patient affected by LES nephritis. Scale bar ¼
50 lm. (D0): High-power magniﬁcation of Notch1þPDXþ cells in
the glomerular tuft. Scale bar ¼ 10 lm. (E): Double label immuno-
ﬂuorescence for Notch1 (green) and CD24 (red) in a patient affected
by FSGS. Scale bar ¼ 20 lm. (F): Double label immunoﬂuores-
cence for Notch3 (green) and PDX (red) in a patient affected by
LES nephritis. Scale bar ¼ 50 lm. (F0): High-power magniﬁcation
of Notch3þPDXþ cells in the glomerular tuft. Scale bar ¼ 20 lm.
(G): Double label immunoﬂuorescence for Notch3 (green) and CD24
(red) in a patient affected by LES nephritis. Scale bar ¼ 50 lm.
(H): Double label immunoﬂuorescence for Notch3 (green) and CD24
(red) in a patient affected by FSGS. Scale bar ¼ 20 lm. (I): Double
label immunoﬂuorescence for Hes1 (green) and PDX (red) in a
patient affected by LES nephritis. Scale bar ¼ 20 lm. (J): Double
label immunoﬂuorescence for Hes1 (green) and CD24 (red) in a
patient affected by LES nephritis. Scale bar ¼ 50 lm. (J0): High-
power magniﬁcation of Hes1þCD24þ renal progenitors. Scale bar
¼ 10 lm. Confocal microscopy was performed on eight healthy
human kidneys, bioptic specimens obtained from 15 patients affected
by LES nephritis and 10 patients affected by FSGS. Representative
images are shown. Topro-3 counterstains nuclei (blue). Abbrevia-
tions: LES, systemic lupus erythematosus; PDX, podocalyxin.
1680 Notch Activation in Renal Progenitorspeaked between 14 and 21 days and then decreased, stabiliz-
ing at pathological values after 28 days, when glomeruloscle-
rosis had already developed in many glomeruli (Fig. 6A).
Consistently with results obtained in human tissues, Notch
activation was not observed in healthy SCID mice (Fig. 6B).
Seven days after adriamycin injection, an activation of the
Notch1 and Notch3 pathways was observed in podocytes, as
demonstrated by double immunoﬂuorescence for Notch1 or
Notch3 and the podocyte marker WT1 (Fig. 6B). In contrast,
renal progenitors were rarely labeled, as demonstrated by dou-
ble immunoﬂuorescence for Notch1 or Notch3 and the mouse
renal progenitor markers [11, 14], Claudin-1 or cytokeratin
(Fig. 6B). After 21 days, Notch1 and Notch3 activation
in podocytes persisted (Fig. 6B). More importantly, a strong
Notch3 activation was observed in renal progenitors
(Fig. 6B), while Notch1 activation was more rarely detected
(Fig. 6B).
To evaluate the role of the Notch pathway in renal injury
and regeneration, SCID mice affected by adriamycin-induced
nephropathy were treated with DAPT or its vehicle. Mice
with adriamycin-induced nephropathy showed high urinary al-
bumin/creatinine ratio levels that were unaffected by injection
of vehicle (Fig. 7A). By contrast, injection of DAPT induced
a reduction of proteinuria after 7 days of treatment, while at
later time points mice treated with DAPT showed a worsening
of renal proteinuria, as reﬂected by signiﬁcantly higher uri-
nary albumin/creatinine ratios (Fig. 7A). Interestingly, the
effects of DAPT were enhanced when severe proteinuria
occurred. In acute kidney injury (day 7), the improvement of
proteinuria induced by injection of DAPT was associated with
reduced glomerular injury, as demonstrated in periodic acid
schiff (PAS)-stained sections (Fig. 7B). Accordingly, in vehi-
cle-treated mice there was a decrease in the number of podo-
cytes, identiﬁed as nephrin-expressing cells, whereas in
DAPT-treated mice podocytes were preserved (Fig. 7B).
However, double label immunoﬂuorescence for H3-Ser10 and
Claudin-1 proliferating progenitors were very rare, suggesting
that the regenerative response had not started yet (Fig. 7C).
By contrast, in chronically injured kidneys (day 21), the wor-
sening of proteinuria induced by injection of DAPT was asso-
ciated with increased glomerular injury, as demonstrated in
PAS-stained sections in comparison with vehicle-treated mice
(Fig. 7D). Consistently, in DAPT-treated mice the number of
podocytes was decreased (Fig. 7D), whereas in vehicle-treated
mice the number of podocytes was signiﬁcantly increased and
consistently higher than the number of podocytes observed in
vehicle-treated mice at day 7. These ﬁndings suggest that on
day 21, in vehicle-treated mice new podocytes had been
regenerated and podocyte injury was partially repaired (Fig.
7D). Accordingly, on day 21, double label immunoﬂuores-
cence for H3-Ser10 and Claudin-1 demonstrated the presence
of numerous proliferating renal progenitors within the Bow-
man’s capsule in vehicle-treated mice (Fig. 7E), suggesting an
ongoing regenerative response of renal progenitors. Strikingly,
in DAPT-treated mice, there was a reduction in the number of
proliferating renal progenitors in comparison with vehicle-
treated mice (Fig. 7E). To further characterize the response to
podocyte injury, double label immunoﬂuorescence for H3-
Ser10 and nephrin (Fig. 7F) was performed. In mice affected
by adriamycin-induced nephropathy, some podocytes in mito-
sis were observed at all the time points analyzed (Fig. 7F).
However, mitotic podocytes were often characterized by
abnormal H3-Ser10 distribution and sometimes by micro/mul-
tinucleation, suggesting that they were undergoing abnormal
mitosis. To support this hypothesis, electron microscopy was
performed, demonstrating that proliferating podocytes were
undergoing aberrant mitosis (Fig. 7G). To address the fre-
quency of this event, the number of mitoses observed in
podocytes was quantiﬁed at different time points. In vehicle-
treated mice with adriamycin nephropathy, mitotic podocytes
were frequently observed, their number being higher at earlier
time points (3.1 6 0.3/glomerulus at day 7 vs. 2.3 6 0.2/glo-
merulus at day 21: p < .05). More than 70% of the mitotic
Figure 6. Upregulation of the Notch signaling components in podo-
cytes and/or renal progenitors of SCID mice with adriamycin ne-
phropathy. (A): Time course assessment of albumin/creatinine ratio as
measured in mice with adriamycin nephropathy (black square) in
comparison with PBS-treated mice (red circle). Data are expressed as
mean 6 SEM as obtained in three independent experiments (n ¼ 12
mice at each time point for each group of treatment); *, p < .05. (B):
Double label immunoﬂuorescence for Notch1 (green) and Claudin-1
(Cla1, red); Notch1 (green) and WT1 (red); Notch3 (green) and cyto-
keratin (CK, red); Notch3 (green) and WT1 (red) in SCID mice
affected by adriamycin nephropathy at different time points. Topro-3
counterstains nuclei (blue). One representative of three independent
experiments performed on a total of 12 mice is shown. Scale bar ¼
20 lm. Abbreviations: PBS, phosphate buffered saline; SCID, severe
combined immunodeﬁcient.
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www.StemCells.comFigure 7. Notch inhibition differentially regulates the balance between podocyte injury and regeneration in mice with focal segmental glomeruloscle-
rosis. (A): Time course assessment of albumin/creatinine ratio as measured in mice with adriamycin nephropathy undergoing daily treatment with vehi-
cle (red circle) or with DAPT (black square). Data are mean 6 SEM as obtained in three independent experiments (n ¼ 15 mice at each time point for
each group of treatment); *, p < .05. (B): Left: PAS staining of renal sections of mice with adriamycin-induced nephropathy treated with vehicle or with
DAPT. Scale bar ¼ 20 lm. Middle: Nephrin staining (green) shows signiﬁcant podocyte depletion in vehicle treated in comparison with DAPT-treated
mice. Topro-3 (blue) counterstains nuclei. Scale bar ¼ 20 lm. Right: Quantitation of number of podocytes (nephrinþ cells)/glomerulus is shown. Data
are mean 6 SEM as obtained in three independent experiments. a versus b, a versus c,a n db versus c; p < .001. (C): Left: Double label immunoﬂuores-
cence for the mitosis marker H3-Ser10 (green) and the mouse renal progenitor marker Cla1 (red) shows the absence of mitotic renal progenitors after 7
days of injury. Topro-3 (blue) counterstains nuclei. Scale bar ¼ 20 lm. Right: Quantitation of number of mitotic progenitors (H3-Ser10þCla1þ cells)/
section is shown. Data are mean 6 SEM as obtained in three independent experiments. (D): Left: PAS staining of renal sections of mice with adriamy-
cin-induced nephropathy treated with vehicle or with DAPT. Scale bar ¼ 20 lm. Middle: Nephrin staining (green) shows podocyte depletion in DAPT-
treated in comparison with vehicle-treated mice. Topro-3 (blue) counterstains nuclei. Scale bar ¼ 20 lm. Right: Quantitation of number of podocytes
(nephrinþ cells)/glomerulus is shown. Data are mean 6 SEM as obtained in three independent experiments. a versus d, a versus e, b versus d,a n dc ver-
sus e; p < .001. (E): Left: Double label immunoﬂuorescence for H3-Ser10 (green) and Cla1 (red) shows signiﬁcantly higher numbers of mitotic renal
progenitors after 21 days of injury in vehicle treated in comparison with DAPT-treated mice. Topro-3 (blue) counterstains nuclei. Scale bar ¼ 20 lm.
Right: Quantitation of number of mitotic progenitors (H3-Ser10þCla1þ cells)/section is shown. Data are mean 6 SEM as obtained in three independent
experiments. f versus g, f versus h,a n dg versus h; p < .001. (F): H3-Ser10 (green) and nephrin (red) shows the occurrence of mitotic podocytes with
abnormal nuclear morphology. Topro-3 (blue) counterstains nuclei. Scale bar ¼ 20 lm. A representative image is shown. (G): Electron microscopy
reveals aberrant mitoses. (G0): Electron micrographs of glomerular podocytes from a mouse with adriamycin nephropathy showing abnormal nuclei and
a micronucleus (arrow) consistent with mitotic catastrophe. (G00): High-power magniﬁcation of (G0) better depicting the micronucleus (arrow). (G000):
High-power magniﬁcation of a heterochromatic nucleus with peculiar symmetrical chromatin pattern, reminiscent of aberrant mitosis. (G0000): A normal
podocyte is shown for comparison. Scale bar ¼ 1 lm. Representative images are shown. Abbreviations: DAPT, N-[N-(3,5-diﬂuorophenacetyl)-L-ala-
nyl]-S-phenylglycine t-butyl ester; PAS, periodic acid schiff.ﬁgures showed major aberrations at all time points analyzed
(73.8% 6 18.3% at day 7 vs. 71.5% 6 14.1% at day 21: NS),
thus conﬁrming that mitosis in podocytes represented a death
event. Consistently, DAPT treatment reduced the number of
mitoses in podocytes (3.1 6 0.3/glomerulus vs. 1.4 6 0.3/glo-
merulus at day 7: p < .05; 2.3 6 0.2/glomerulus vs. 1.1 6
0.3/glomerulus at day 21: p < .05).
DISCUSSION
The molecular mechanisms regulating the proliferation of re-
nal progenitors, as well as the cell fate determination in the
podocyte lineage are unknown. Here, we demonstrate the role
of the Notch signaling pathway in both these processes.
The ﬁrst important ﬁnding emerging from this study was
that Notch activation triggers the expansion of renal progeni-
tors by promoting their entry into the S-phase of the cell
cycle and mitotic division. This represents the ﬁrst demonstra-
tion of a signaling pathway that can promote the regenerative
capacity of renal progenitor cells. Interestingly, an attenuation
of Notch activity was observed during the commitment of re-
nal progenitors to the podocyte cell fate. However, Notch
downregulation was neither sufﬁcient nor necessary for the
acquisition of a podocyte phenotype, but an impaired down-
regulation of the Notch pathway led to podocyte death.
Indeed, renal progenitor differentiation into podocytes was
associated with cell cycle checkpoint activation and G2/M
arrest, reﬂecting an intrinsic barrier to replication of mature
podocytes. Persistent activation of the Notch pathway induced
podocytes to cross the G2/M checkpoint, resulting in cytoskel-
eton disruption and cell death.
The pivotal role of podocyte depletion in glomerulosclero-
sis has been established [1–5]. However, the mechanisms re-
sponsible for podocyte loss in response to injury are still
mostly unknown. Some authors have suggested that podocytes
might be lost because of apoptosis and/or cell detachment,
but in several glomerular disorders apoptotic podocytes were
not observed, suggesting that different mechanisms of cell
death may be involved [5, 31–33]. In this study, we provide
the ﬁrst evidence that podocytes can die by mitotic catastro-
phe induced by Notch activation. Mitotic catastrophe is a cell
death mode occurring either during or shortly after a dysregu-
lated/failed mitosis and can be accompanied by morphological
alterations including micro/multinucleation, which is the only
sign that distinguishes mitotic catastrophe from either apopto-
sis or necrosis [34, 35]. Although mitotic catastrophe was not
previously described as a mechanism of podocyte death, there
is evidence to suggest that podocytes undergo catastrophic mi-
tosis in glomerular disorders. Indeed, the presence of multi-
nucleated podocytes has been nonspeciﬁcally reported in a va-
riety of experimental [36–39] as well as human [40–43]
glomerulopathies.
The results of the present study also suggest that podo-
cytes can initiate DNA synthesis, but cannot undergo cytoki-
nesis. Indeed, cell division appears to be possible only for
renal progenitors, which display a cuboidal/ﬂat cell shape
with simple cytoskeleton architecture that allows progression
through mitosis and proliferation. As soon as renal progeni-
tors differentiate into the octopus-like phenotype of the
mature podocyte, they lose their ability for cell multiplica-
tion. Indeed, on re-entering the cell cycle podocytes would
destroy the speciﬁcally arranged cytoskeletal organization
[44–46], including actin systems, which is essential to main-
tain their integrity and permselectivity. Consistently, renal
progenitor differentiation toward the podocyte lineage is
characterized by upregulation of the p21
Cip1/WAF-1 and
p27
Kip1 inhibitors, which impair the capacity of these cells
to progress through the cell cycle. Downregulation of
p21
Cip1/WAF-1 and p27
Kip1 induced by Notch activation
forces progression toward mitosis of a cell that cannot
assemble an efﬁcient mitotic spindle, because it poorly
expresses Aurora kinase B, which is essential for cytokine-
sis. Taken altogether, these results suggest that entry into
mitosis for podocytes is a trigger for death, thus explaining
why podocytes cannot be replaced through division of adja-
cent podocytes. However, even glomerular disorders with
severe injury can undergo regression and remission, suggest-
ing that podocyte loss can be rescued [47, 48].
The discovery of renal progenitors [6] as well as of their
ability to generate novel podocytes [10, 11] are consistent
with the observation provided in this study that the outcome
of glomerular disorders depends on a balance between podo-
cyte injury and regeneration provided by renal progenitors.
These results raise some additive questions. For example,
which may be the stimulus(i) that induce Notch upregulation
in podocytes and/or progenitors. Previous studies demon-
strated that transforming growth factor-beta (TGF-b) [49,
50], which is released following podocyte injury or proteinu-
ria [51], is a powerful Notch activator, suggesting that Notch
activation may represent an adaptive response to podocyte
injury. Interestingly, although the biological effects of dis-
tinct Notch receptors appeared similar, a differential expres-
sion of Notch receptor subtypes was observed in renal pro-
genitors or podocytes in FSGS and in LES nephritis, Notch3
being the prevalent Notch receptor subtype upregulated in
renal progenitors. These results suggest that a differential
modulation of injury and regeneration through distinct Notch
receptors may occur. Further studies are required to address
this point.
Finally, our results provide an explanation for the obser-
vations of two previous studies, showing that transgenic
mice carrying a speciﬁc activation of the N1ICD in podo-
cytes displayed chronic glomerular injury with albuminuria
[50, 52]. However, while active Notch1 expression induced
podocyte death in one study [50], it led to proliferation of
cells with an immature podocyte phenotype within glomeruli
in the other [52]. The results of our study allow to reconcile
these apparently contradictory observations. Indeed, these
two studies differed for the timing of Notch1 expression,
suggesting that while active Notch1 expression induced
death in mature podocytes, it led to their proliferation if
expressed before their full differentiation [53]. According to
our results, Notch activation in podocyte progenitors induces
proliferation, thus suggesting that in the study by Waters
et al. [52], podocyte injury induced by Notch activation in
differentiated podocytes may have been partially overcome
by Notch activation in podocyte progenitors, explaining the
milder proteinuria and less severe renal failure in compari-
son with Niranjan et al. [50].
CONCLUSION
Taken altogether, the results of this study provide the ﬁrst
demonstration that the severity of glomerular disorders
depends on the Notch pathway-regulated balance between the
degree of podocyte injury and the amount of regeneration pro-
vided by renal progenitors, thus opening the previously
unthinkable possibility that in patients with glomerular
Lasagni, Ballerini, Angelotti et al. 1683
www.StemCells.comdisorders this balance might be manipulated to trigger podo-
cyte regeneration.
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